tirzepatide for anti inflammatory GLP-1 drugs calm inflammation beyond diabetes and weight loss Tirzepatide Weight Loss Injections |
Description
The injectable formulation (tirzepatide/glycine/B12) is administered as a weekly subcutaneous injection and has more predictable bioavailability based on the extensive clinical trial data for injectable tirzepatide
Targeting the GIPR for obesity: To agonize or antagonize
Zepound and Wegovy are two of the latest FDA-approved drugs on the market to treat severe obesity and chronic weight management
The 60 mg vial costs more upfront than smaller sizes
Patoulias D., Doumas M., and Papadopoulos C., MetaAnalysis Assessing the Effect of Tirzepatide on the Risk for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus, American Journal of Cardiology 173 (2022): 157158
